To investigate the eect of p33
Introduction
The importance of normal p53 expression in reducing the probability of carcinogenesis is now universally accepted. Early experiments demonstrated that constitutive overexpression of wild-type p53 (wtp53) abrogates oncogene-mediated transformation and inhibits the growth of various tumor cell types (Eliyahu et al., 1989; Finlay et al., 1989; Baker et al., 1990; Chen et al., 1990; Diller et al., 1990) . When wtp53 was overexpressed in a murine myeloid leukemic cell line that lacks endogenous p53 expression, the cells rapidly lost viability in a manner characteristic of apoptosis (Yonish-Rouach et al., 1991) .
It has been well documented that p53 transactivates several genes including p21 WAF1/Cip1/Sdi , Bax and Mdm2 (El-Deiry et al., 1993; Miyashita and Reed, 1995; Barak and Oren, 1992) . p21 encodes an inhibitor of cyclindependent kinases (cdks) (Gu et al., 1993; Harper et al., 1993; Xiong et al., 1993) . The retinoblastoma tumor suppressor protein, Rb, can control cell cycle progression by regulating the transactivating activity of E2F (Sherr, 1996) . Rb is inactivated by phosphorylation by cdc2, cdk2 and cdk4/cdk6 kinases (Knudsen and Wang, 1996; Zarkowska and Mittnacht, 1997) , and thus the induction of p21 by p53 accounts for p53-induced growth arrest. Bax is a proapoptotic protein, and therefore might have a role in the induction of apoptosis by p53 (Miyashita and Reed, 1995) . However, p53-induced apoptosis was also reported to be mediated by other molecules such as Fas (Owen-Schaub et al., 1995) , IGF-BP3 (Buckbinder et al., 1995) , cathepsin D (Wu et al., 1998) , PIG3 (Polyak et al., 1997) , cyclin G (Okamoto and Prives, 1999) , MCG10 (Zhu and Chen, 2000) , Noxa (Oda et al., 2000a) and AIP1 (Oda et al., 2000b) . Mdm2 is an oncogenic protein (Fakharzadeh et al., 1991) , the tumorigenic activity of which is due, at least in part, to abrogation of p53 transcriptional and growth-suppressive function (Chen et al., 1996; Haupt et al., 1996) . This inhibition is mediated largely by promoting the rapid degradation of p53 by the proteasome (Haupt et al., 1997; Kubbutat et al., 1997; Oren, 1999) .
A novel candidate tumor-suppressor gene p33 has been isolated by using a method that combined subtractive hybridization of cDNAs from normal and cancerous cells with an in vivo selection assay (Garkavtsev et al., 1996) . Overexpression of p33 inhibits cell cycle progression from G 0 /G 1 to S phase (Garkavtsev et al., 1996) , and decreased p33 expression was observed in breast cancers (Toyama et al., 1999; Tokunaga et al., 2000) , gastric cancers (Oki et al., 1999) , lymphoid tumor cell lines (Ohmori et al., 1999) and esophageal squamous cell cancers (ESCC) (Chen et al., 2001) . Tumor-speci®c mutations were detected in the p33 gene in head and neck squamous cell carcinomas (Gunduz et al., 2000) and ESCC (Chen et al., 2001) . In addition to the negative regulation of cell proliferation, p33 was also suggested to be involved in the control of cellular aging, anchorage dependence, apoptosis and DNA repair (Garkavtsev et al., 1996; Helbing et al., 1997; Cheung et al., 2001) . Most, if not all, of these biological eects of p33 can be ascribed to physical association with p53, since neither p33 nor p53 can, on its own, cause growth inhibition when the other is suppressed (Garkavtsev et al., 1998) . Esophageal cancer is a highly malignant disease. Although combination therapy of radiation and chemotherapy is used most widely, a satisfactory treatment has not yet been established due to severe side eects and resistance acquisition (Houghton et al., 1986; Aschele et al., 1992) . Cancer gene therapy using p53 has been developed as an alternative to conventional therapy (Roth et al., 1996) because mutations in this gene are found in more than 50% of esophageal cancers (Hollstein et al., 1990; Bennett et al., 1992; Nabeya et al., 1995; Kobayashi et al., 1999) . Clinically, recombinant adenoviral vectors are expected to provide suitable vehicles for introducing a gene of interest into cancer cells due to their high infectivity. Although some studies have been reported on esophageal cancer gene therapy, more preclinical studies are required to con®rm the anti-cancer eect on esophageal carcinoma cells of adenoviral-mediated p53 gene transfer. In the present study, we observed a marked facilitation of adenoviral wtp53-induced apoptotic cell death by overexpression of p33 in T.Tn human esophageal carcinoma cells. Possible mechanisms for p53-mediated apoptosis are discussed.
Results

Transfection with p33
T.Tn is an esophageal carcinoma cell line (Takahashi et al., 1990 ) with a single point mutation at codon 258 in the p53 gene in one allele (Shimada et al., 2001 ). p33 cDNA in T.Tn cells was ampli®ed by RT ± PCR using the total RNA fraction according to the method of Toyama et al. (1999) . Thereafter, direct sequencing of the products showed that there was no alteration in p33 sequence (data not shown). To investigate the eects of overexpression of p33, a p33 cDNA construct in the eukaryotic constitutive expression vector pcDNA3 was transfected into T.Tn cells. The level of expression of p33 in G418-selected clones was examined by Western blotting. One of the transfected clones, TnG-4, expressed a high level of p33 while the parental T.Tn cells and the empty vector-transfected control clone, TnV-3, contained barely detectable levels of p33 ( Figure 1a ). Doubling times of T.Tn and TnG-4 cells were approximately 21 and 33 h, respectively, which was consistent with the designation ING1 (inhibitor of growth) for p33. Anchorage-independent growth was almost completely suppressed in TnG-4 cells compared to T.Tn cells (Figure 2) . Thus, the introduced p33 appeared to be eective in suppression of malignantly transformed phenotypes.
Enhanced cell death of p33-expressing cells after infection with Ad-p53
We examined the eect of infection with Ad-p53 and Ad-LZ, which harbored human wild-type p53 and E. coli Lac Z, respectively, into T.Tn and TnG-4. Cell viability decreased with increasing MOI (Figure 3a) . Ad-p53 exerted an obvious cytotoxic eect on T.Tn cells at MOI higher than 100 whereas only a marginal but reproducible decrease in the viability was observed after infection with a control virus Ad-LZ at MOI higher than 500. As compared to T.Tn cells, TnG-4 cells showed a higher susceptibility to Ad-p53 infection. Some decrease in the viability was observed in TnG-4 cells at MOI as low as 10. The viability of T.Tn and TnG-4 cells after infection with Ad-p53 at MOI of 50 was approximately 60 and 20%, respectively.
To examine further the synergistic eects of p53 and p33, T.Tn cells were co-infected with Ad-p53 and Adp33. The reduction of viability was more prominent after infection with both Ad-p53 and Ad-p33 together compared to either alone ( Figure 3b ). Similar synergistic eects were also observed in another human esophageal carcinoma cell line, YES6, which has no mutation in p53 exons (Y Nabeya and H Shimada, unpublished observation). However, the synergism in this line was less marked compared to T.Tn cells, i.e. infection with Ad-p33 at MOI 80 in YES6 cells caused similar eects to those at MOI 40 in T.Tn cells (Figure 3c ).
Induction of apoptosis after infection with Ad-p53
The induction of apoptotic cell death in Ad-p53-infected cells was examined by TUNEL staining. T.Tn and TnG-4 cells were stained 24 h after infection with Ad-p53 at MOI of 50. Neither a signi®cant morphological change nor an increase in TUNEL-positive cells was observed in T.Tn cells (Figure 4 ). In contrast, severe morphologically-detectable damage and dense TUNEL-staining were evident in TnG-4 cells, suggesting that the enhanced cell death of TnG-4 cells after infection is apoptotic.
Expression of p53 and related molecules
To investigate further the dierence between T.Tn and TnG-4 cells regarding mechanisms of cell death, the expression of p53 and p53-related molecules was examined by Western blotting. Cells were infected with Ad-p53 or Ad-LZ at MOI of 50 and cultured for 4, 8 and 24 h. Cytoplasmic and nuclear extracts were then prepared and analysed.
The expression of p53 in nuclei was detected at 8 h after infection with Ad-p53 and was further increased at 24 h ( Figure 5a ). Because the increase in p53 expression was not observed in Ad-LZ-infected cells, it can be attributed to the expression of viral proteins. However, there was no signi®cant dierence in p53 levels between T.Tn and TnG-4 cells. The level of expression of p53 in the cytoplasm, as well as ubiquitinated p53, was also similar in both T.Tn and TnG-4 cells (Figure 5b) .
It was previously shown that Bax gene is activated by wtp53 (Miyashita and Reed, 1995) . In our study, the expression of Bax was apparently not enhanced by adenoviral p53 in either T.Tn or TnG-4 cells ( Figure  5c ). At 24 h after infection with Ad-p53, the level of Bax was even reduced in both cells.
Down-regulation of NF-kB p65 and p50 by p53 was recently shown by Shao et al. (2000) . The expression of NF-kB p65 increased gradually up to 8 h after infection and thereafter decreased (Figure 5d ). Although the level of p65 in TnG-4 cells was lower than in T.Tn cells, p65 was not detectable in either 24 h after infection with Ad-p53. This suggests that the reduced expression of p65 cannot account for the dierential induction of apoptosis between TnG-4 and T.Tn cells. Similar Western blotting analysis showed no apparent dierence in levels of NF-kB p50, Fas and cyclin G proteins between T.Tn and TnG-4 cells after infection with Ad-p53 (data not shown).
The expression of Mdm2 was undetectable in uninfected cells but clearly observed 8 h after infection of the two cell lines (Figure 5e ). The Mdm2 levels continued to increase up to 24 h after infection. The increase in Mdm2 level in TnG-4 cells was much more prominent than in T.Tn cells. Although Mdm2 was reported to have a role in ubiquitination of p53 (Haupt et al., 1997; Kubbutat et al., 1997) , the level of ubiquitinated p53 was not signi®cantly altered in T.Tn and TnG-4 cells (Figure 5b) .
The induction of p21 by Ad-p53 infection was more noticeable in TnG-4 than in T.Tn cells (Figure 5f ). The expression of p21 paralleled that of p53, i.e. the level of p21 increased at 8 h and further increased at 24 h after infection with Ad-p53. Extended exposure of the blot in Figure 5f revealed that the basal expression level of p21 was higher in TnG-4 cells than in T.Tn cells (data not shown).
To determine whether the expressed p21 aected the kinase activity of cdks, phosphorylation levels in Rb protein were examined using phospho-speci®c anti-Rb antibodies. Phosphorylation at Ser-780 in Rb decreased at 8 h after infection in T.Tn cells, with a similar decrease in TnG-4 cells (Figure 6a ). Likewise, phosphorylation at Ser-807/811 in Rb was also reduced in both T.Tn and TnG-4 cells (Figure 6b ). Thus, although decreased Rb phosphorylation levels were observed concomitantly with the increase in p21 expression, the dierential induction of apoptosis between T.Tn and TnG-4 cells cannot be attributed to an inhibitory eect of p21 on cdk-mediated Rb phosphorylation.
Effect of Mdm2 on p53-mediated death
To examine whether Mdm2 can aect the survival of Ad-p53-infected cells, T.Tn and TnG-4 cells were transiently transfected with an expression plasmid for either wild-type Mdm2 or mutant Mdm2. The Mdm2 mutant lacked the Ring ®nger domain, and thus is unable to promote the degradation of p53 (Sionov et al., 1999) . Twenty-four hours after transfection, cells were infected with Ad-p53 at MOI of 12.5, 25, 50, 100 and 200, and then kept in culture for an additional 5 days. The eect of Mdm2 on cell viability was measured by the MTT assay. The percent viabilities of infected versus uninfected cells are shown in Figure  7 . Similar to the results presented in Figure 3 , the viability decreased with increasing MOI. The survival of T.Tn cells was higher than that of TnG-4 cells at any MOI. It should be noted that the viability of mutant Mdm2-transfected cells was higher than that of wild-type Mdm2-or vector-transfected cells. A signi®cant dierence between mutant Mdm2-and vectortransfected cells was observed at MOI of 100 and 200 in T.Tn cells and at MOI between 50 and 100 in TnG-4 cells (indicated by asterisks in Figure 7) . These results imply that the marked decrease in viability observed in TnG-4 cells after Ad-p53-infection was partly recovered by expression of mutant Mdm2. However, the viability of T.Tn cells after Ad-53 infection was similar in both vector-and wild-type Mdm2-transfected T.Tn cells, suggesting that the overexpression of wild-type Mdm2 alone was not sucient to markedly potentiate p53-mediated apoptosis. 
Discussion
We have isolated a stable transfectant, TnG-4, which expresses a large amount of p33 (Figure 1a) . TnG-4 cells had a slower growth rate and a marked reduction in anchorage-independent growth compared to the parental T.Tn cells (Figure 2) . These results con®rmed the growth-inhibitory and tumor-suppressive activity of p33 reported by Garkavtsev et al. (1996 Garkavtsev et al. ( , 1998 . Furthermore, apoptotic cell death in TnG-4 cells was more prominent than in T.Tn cells (Figures 3a and 4) . This demonstrated that p33 cooperates with p53 in the Immunoblot analysis of Ad-p53 or Ad-LZ-transfected cells. The cells were cultured for 4, 8 and 24 h after infection with Ad-p53, or cultured for 4 and 24 h after infection with Ad-LZ.7represents the untreated control cells. Extracts from nuclear (a) and cytoplasmic fractions (b ± f) were probed with anti-p53 (a, b), anti-Bax (c), anti-NF-kB p65 (d), anti-Mdm2 (e) and anti-p21 (f) antibodies. The antibody used in b was Bp53-12 (Santa Cruz Biotechnology), which can recognize ubiquitinated p53 in addition to non-ubiquitinated p53. To examine the bands of the ubiquitinated p53, the blot of b was exposed much longer as compared to that of a Figure 6 Immunoblot analysis of phosphorylated Rb. Nuclear extracts of T.Tn and TnG-4 cells after infection with Ad-p53 were analysed by immunoblotting. Phosphorylated Rb-speci®c antibodies (New England Biolabs) were used to examine the levels of Rb phosphorylation. The anti-Rb antibodies used were speci®c for phosphorylation at Ser-780 (a) and at induction of apoptosis in this human esophageal cancer cell line. Similar synergism between p33 and p53 was also reported in a human glioma cell line by Shinoura et al. (1999) .
We then asked which gene(s) may be involved in the cell death induced by p33 overexpression and viral wtp53 infection. We observed that the expression of p21 and Mdm2 but not Bax was upregulated after Adp53 infection (Figure 5c , e and f). The lack of Bax induction by Ad-p53 infection suggests that this molecule may not contribute to p53-induced apoptosis in this context. As an alternative explanation, the level of Bax expression in this cell line is already high (Figure 5c ), and therefore, a further increase may be dicult to detect. Stimulation of p53-dependent induction of p21 by p33 was previously reported by Garkavtsev et al. (1996) , and may contribute to the slow proliferation rate of TnG-4 cells. However, despite the dierent levels of p21 induction between T.Tn and TnG-4 cells, decreased phosphorylation levels of Rb protein on Ser-780 and on Ser-807/811 were not signi®cantly altered (Figure 6 ). Increasing evidence has shown that p21 has an anti-apoptotic activity (Lu et al., 1998; Bissonnette and Hunting, 1998; Asada et al., 1999) . Therefore, the high induction level of p21 in TnG-4 cells cannot account for the eective induction of apoptosis by Ad-p53. Rather, it is reasonable to assume that wtp53 may overcome this eect of p21 as suggested by Kagawa et al. (1997) .
The expression of NF-kB p65 (Figure 5d ) and p50 (data not shown) was initially increased, but by 8 h post-Ad-p53 infection decreased again. Similar Ad-p53-induced decreases in p65 and p50 were also reported by Shao et al. (2000) . However, the decrease in p65 was observed in both parent T.Tn and TnG-4 cells, and also detected in control Ad-LZ-infected cells ( Figure  5d) . Consequently, the dierence in NF-kB expression may not be relevant to the observed dierences in apoptosis.
We also found a marked stimulation of Mdm2 expression in TnG-4 cells after Ad-53 infection ( Figure  5e ). Although Mdm2 is a key player in the regulation of p53 stability (Haupt et al., 1997; Kubbutat et al., 1997; Oren, 1999) , no signi®cant alteration in p53 protein levels was observed between T.Tn and TnG-4 cells (Figure 5a,b) . Thus, it is improbable that in p33-expressing cells, upregulated Mdm2 expression decreased the half life of p53. This may suggest the uncoupling of p53 and Mdm2 in the presence of excess p33. In the absence of negative regulation by Mdm2, the induction of p53 apoptotic target genes may be enhanced. These genes can include Bax, Fas, IGF-BP3, cathepsin D, PIG3, cyclin G, MCG10, Noxa and AIP1 (Miyashita and Reed, 1995; Owen-Schaub et al., 1995 , Buckbinder et al., 1995 Wu et al., 1998; Polyak et al., 1997; Okamoto and Prives, 1999; Zhu and Chen, 2000; Oda et al., 2000a,b) .
Alternatively, the enhanced expression of Mdm2 may be directly involved in induction of apoptosis. This is consistent with the result that mutant Mdm2 but not its wild-type reversed the reduction of survival induced by infection with Ad-p53 (Figure 7 ). It has recently been reported by Hsing et al. (2000) that aryl hydrocarbons such as benzo[a]pyrene (BaP) induced apoptosis via enhanced expression of Mdm2 independently of p53. Enforced expression of exogenous Mdm2 further stimulated BaP-induced apoptosis. Rb may have a role in protection against DNA-damage- (Knudsen et al., 2000) , and E2F-1 as well as E2F-2, E2F-4 and DP-1 was reported to possess a pro-apoptotic activity (DeGregori et al., 1997; Bargou et al., 1996; Dirks et al., 1998; Chang et al., 2000) . Because Mdm2 can bind to Rb (Sun et al., 1998) , suppression of Rb and, thereby, activation of the E2F complex may account for the mechanism of Mdm2-mediated apoptosis. Inasmuch as E2F acts downstream of p21, the possible involvement of E2F activation in Ad-p53-induced apoptosis in TnG-4 cells is in good agreement with the result that the induction of apoptosis occurred despite the high expression of p21 (Figure 5f ).
In addition to wtp53-induced apoptosis, we observed a signi®cant decrease in cell viability after infection with Ad-LZ at MOI higher than 500 (Figure 3) . Infection with the empty replication-de®cient adenovirus also caused a similar decrease in cell survival (data not shown). Western blotting revealed that endogenous p53 expression was elevated to some extent 24 h after infection with Ad-LZ at MOI of 50 (Figure 5a,b) . Therefore, it is evident that even without oncogene or tumor suppressor gene involvement, virus infection itself provokes a speci®c signal transduction pathway which can then aect gene expression including endogenous wtp53. Although the signaling caused by virus infection was much weaker than that induced by viral wtp53 (Figure 5 ), caution should be exercised at high-MOI to prevent unexpected side eects in any clinical application.
In this context, it is important to achieve a high eciency of gene therapy. The present work suggests that the level of expression of p33 is one useful prognostic factor for ecient Ad-p53 gene therapy. It will be important to elucidate the eects of all of the other p53-associated molecules on wtp53-mediated induction of apoptosis.
Materials and methods
Cells
A human esophageal cancer cell line T.Tn (Shimada et al., 2001) was obtained from the Japan Cell Research Bank (Ibaraki, Japan), and the YES6 cell line was described previously (Oka et al., 1995) . Cells were cultured in Dulbecco's modi®ed Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum.
Adenoviral vectors
Recombinant adenoviral vectors used in this study were derived from the replication-de®cient (del E1, del E3) adenovirus type 5, which harbors E. coli Lac Z (Ad-LZ) or human wild-type p53 cDNA (Ad-p53) at the E1-deleted region under the control of the cytomegalovirus (CMV) promoter. These viruses were provided by Dr Toshiyoshi Fujiwara (Okayama University Medical School), and also prepared by lysis of infected 293 cells according to the method of Zhang et al. (1995) as described (Shimada et al., 2001) . Titers of the viral stocks were determined by plaqueforming assay using 293 cells.
Construction of an expression vector for p33 ING1
p33
ING1 cDNA (pcAhp33) was obtained from the Riken Gene Bank (Ibaraki, Japan). An EcoRI insert was subcloned into an EcoRI site in the downstream region of the CMV promoter of pcDNA3 (Invitrogen, Groningen, The Netherlands). Ad-p33 was prepared as described (Shinoura et al., 1999) .
Transfection
The p33 cDNA plasmid was transfected into T.Tn cells using Lipofectamine (Invitrogen), and the cells were cultured in medium containing G418 (300 mg/ml) for 2 weeks. Expression plasmids of human wild-type Mdm2 (pCMV-Neo-Bammdm2) and human mutant Mdm2 (pCMV-Neo-Bamhdm2Dring) described previously (Sionov et al., 1999) were transiently transfected into T.Tn and TnG-4 cells using Lipofectamine PLUS (Invitrogen).
Western blotting
T.Tn and TnG-4 cells were infected with Ad-p53 or Ad-LZ at MOI of 50, and further cultured for 4, 8 and 24 h. Cells were then washed three times with phosphate-buered saline (PBS) and lysed in 0.5% Nonidet P-40, 20 mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 mM phenylmethylsulfonyl¯uoride, 50 mM leupeptin, 50 mM antipain, 50 mM pepstatin A and 50 mM ALLN (Hiwasa et al., 1990) for 10 min at 48C. The cell lysate was centrifuged at 13 000 g for 10 min and the supernatant was used as the cytoplasmic cell extract. The pellet was used to prepare nuclear extract (Hiwasa and Sakiyama, 1996) . The samples were then analysed by immunoblotting using antip53 (Bp53-12), anti-Bax, anti-Mdm2, anti-p33 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), anti-p53 and anti-p21 monoclonal antibodies (Transduction Laboratories, Lexington, KY, USA), and phospho-speci®c anti-Rb antibodies (New England Biolabs, Beverly, MA, USA), followed by detection using ImmunoStar Reagents (Wako Pure Chemicals, Kyoto, Japan).
Assay for anchorage-independent growth
Cell growth in soft agar medium was examined as described previously (Hiwasa et al., 1987 (Hiwasa et al., , 1996a . Two thousand cells were plated in soft agar medium which contained 0.4% SeaPlaque Agarose, 10% fetal bovine serum and Dulbecco's modi®ed Eagle's medium. After culture for 18 days, colonies of which the diameters were larger than 0.1 mm were scored. The cloning eciency was calculated by dividing the colony number by the number of cells plated.
MTT assay for assessing cell viability
The inhibitory eects of viruses on the proliferation of cultured cells were examined by the MTT assay of Mosmann (1983) as described previously (Hiwasa et al., 1996b) . Five thousand cells were placed in each well and cultured for 5 days. Quantitation of cell viability was carried out by measuring the absorbance at 570 nm after incubation with MTT (3-(4,5-dimethylthiozol-2-yl)-2,5-diphenyltetrazolium bromide) (Sigma) for 4 h. The results are shown as the percentage of control.
TUNEL staining
The TUNEL assay (Gorczyca et al., 1992) was performed using the`Apoptosis in situ Detection Kit' (Wako Pure Chemicals) according to the manufacturer's instructions. Brie¯y, cells were ®xed in 3.7% formalin in PBS for 10 min at room temperature, and were permeabilized by treatment with 0.1% Triton X-100 for 2 min at 08C. The 3'-hydroxyl ends of DNA were labeled with¯uorescein-dUTP by terminal deoxynucleotidyl transferase at 378C for 30 min. The labeled DNA was detected by incubation with peroxidase-conjugated anti-¯uorescein antibody at 378C for 10 min, followed by incubation with diaminobenzidine.
Abbreviations wtp53, wild type p53; Ad-p53, recombinant wild-type p53 adenoviral vector; Ad-LZ, recombinant LacZ adenoviral vector; CMV, cytomegalovirus; MOI, multiplicity of infection; MTT, 3-(4,5-dimethylthiozol-2-yl)-2,5-diphenyltetrazolium bromide; PBS, phosphate-buered saline; TUNEL, terminal deoxynucleotidyl transferase-mediated nick end-labeling; BaP, benzo[a]pyrene; ALLN, acetyl-LeuLeu-norleucinal.
